Average Co-Inventor Count = 5.99
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (38 from 1,323 patents)
2. Abbvie Inc. (24 from 822 patents)
3. Abbott Laboratories Corporation (15 from 4,171 patents)
4. Pharmacia Corporation (13 from 200 patents)
5. Other (3 from 831,952 patents)
6. Abbvie Bahamas Limited (6 patents)
93 patents:
1. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use
2. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
3. 9718821 - Pyridopyrimidinone inhibitors of kinases
4. 9650358 - Pyridine CDK9 kinase inhibitors
5. 9346813 - Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors
6. 9328112 - Tetracyclic CDK9 kinase inhibitors
7. 9283222 - Inhibitors of poly(ADP-ribose)polymerase
8. 9212192 - Bicyclic carboxamide inhibitors of kinases
9. 9181239 - Pyridopyrimidinone inhibitors of kinases
10. 9181246 - Pyrrolopyridine inhibitors of kinases
11. 9163007 - 5-substituted indazoles as kinase inhibitors
12. 9073922 - Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors
13. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases
14. 8969375 - CDK9 kinase inhibitors
15. 8859546 - Picolinamide inhibitors of kinases